← Leaderboards
Riqiang Yan
Cleveland Clinic Lerner Col/Med-Cwru
$28,575,192
Attributed
$29,071,460
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,071,460 · 10
By mechanism
R01$14,711,404 · 4
RF1$13,473,181 · 4
R21$886,875 · 2
Top collaborators
- Srdjan D Antic2 shared
- Rong Xu1 shared
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposS DiseaseBrainBeta-Site App Cleaving Enzyme 1Amyloid DepositionAmyloid Beta-Protein PrecursorSenile PlaquesTransgenic MiceCognitive FunctionMouse ModelKnockout MiceGenerationsMolecularPathogenesisSynaptic FunctionIn VivoCleaved CellAmyloid PeptideNeuronsMediatingAdultAmyloid Beta-ProteinPreventAffect
Grant awards (47)
Inhibition of BACE1 for benefiting Alzheimer's patients$761,875
R01 · FY2025 · AG · contact PI
Inhibition of BACE1 for benefiting Alzheimer's patients$777,423
R01 · FY2024 · AG · contact PI
Roles of reticulon proteins in neurodegenerative disorders$748,128
R01 · FY2024 · AG · contact PI
BACE1 in neurodegeneration and neurological dysfunction$728,661
R01 · FY2024 · NS · contact PI
Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration$2,132,716
RF1 · FY2023 · AG · contact PI
Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration$28,267
RF1 · FY2022 · AG · contact PI
BACE1 in neurodegeneration and neurological dysfunction$2,139,908
RF1 · FY2021 · NS · contact PI
Population Network Responses in AD Model Animals$205,000
R21 · FY2021 · AG
Roles of reticulon proteins in neurodegenerative disorders$3,031,508
RF1 · FY2020 · AG · contact PI
BACE1 in neurodegeneration and neuronal dysfunction$530,047
R01 · FY2020 · NS · contact PI
Population Network Responses in AD Model Animals$246,000
R21 · FY2020 · AG
BACE1 in neurodegeneration and neuronal dysfunction$530,047
R01 · FY2019 · NS · contact PI
Roles of reticulon proteins in neurodegenerative disorders$431,959
R01 · FY2019 · AG · contact PI
Inhibition of BACE1 for benefiting Alzheimer's patients$3,255,415
RF1 · FY2018 · AG · contact PI
BACE1 in neurodegeneration and neuronal dysfunction$530,047
R01 · FY2018 · NS · contact PI
Roles of reticulon proteins in neurodegenerative disorders$428,267
R01 · FY2018 · AG · contact PI
Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration$2,776,711
RF1 · FY2017 · AG · contact PI
An Integrated Reverse Engineering Approach Toward Rapid drug Re positioning for Alzheimer's Disease$541,537
R01 · FY2017 · AG
BACE1 in neurodegeneration and neuronal dysfunction$530,674
R01 · FY2017 · NS · contact PI
Roles of reticulon proteins in neurodegenerative disorders$425,582
R01 · FY2017 · AG · contact PI
Inhibition of BACE1 for benefiting Alzheimer's patients$324,925
R01 · FY2017 · AG · contact PI
Role of the CX3CL1 C-terminus in reversing age-dependent Alzheimers neurodegeneration$108,656
RF1 · FY2017 · AG · contact PI
Supplement for BACE1 in neurodegeneration and neuronal dysfunction$25,000
R01 · FY2017 · NS · contact PI
BACE1 in neurodegeneration and neuronal dysfunction$530,674
R01 · FY2016 · NS · contact PI
Roles of reticulon proteins in neurodegenerative disorders$425,582
R01 · FY2016 · AG · contact PI
Inhibition of BACE1 for benefiting Alzheimer's patients$324,925
R01 · FY2016 · AG · contact PI
Roles of reticulon proteins in neurodegenerative disorders$425,582
R01 · FY2015 · AG · contact PI
BACE1 in neurodegeneration and neuronal dysfunction$343,438
R01 · FY2015 · NS · contact PI
Inhibition of BACE1 for benefiting Alzheimer's patients$315,177
R01 · FY2015 · AG · contact PI
The secreted form of Neuregulin-1 in schizophrenia$198,125
R21 · FY2015 · MH · contact PI
BACE1 in neurodegeneration and neuronal dysfunction$340,004
R01 · FY2014 · NS · contact PI
Inhibition of BACE1 for benefiting Alzheimer's patients$324,925
R01 · FY2014 · AG · contact PI
Roles of reticulon proteins in neurodegenerative diseases$305,590
R01 · FY2014 · AG · contact PI
The secreted form of Neuregulin-1 in schizophrenia$237,750
R21 · FY2014 · MH · contact PI
BACE1 in neurodegeneration and neuronal dysfunction$331,418
R01 · FY2013 · NS · contact PI
Inhibition of BACE1 for benefiting Alzheimer's patients$324,925
R01 · FY2013 · AG · contact PI
Roles of reticulon proteins in neurodegenerative diseases$288,783
R01 · FY2013 · AG · contact PI
BACE1 in neurodegeneration and neuronal dysfunction$343,438
R01 · FY2012 · NS · contact PI
Roles of reticulon proteins in neurodegenerative diseases$305,590
R01 · FY2012 · AG · contact PI
BACE1 in neurodegeneration and neuronal dysfunction$343,438
R01 · FY2011 · NS · contact PI
Roles of reticulon proteins in neurodegenerative diseases$305,590
R01 · FY2011 · AG · contact PI
Roles of reticulon proteins in neurodegenerative diseases$317,925
R01 · FY2010 · AG · contact PI
Roles of Reticulon proteins in neurodegenerative disease$291,450
R01 · FY2009 · AG · contact PI
Roles of Reticulon proteins in neurodegenerative disease$291,450
R01 · FY2008 · AG · contact PI
Roles of Reticulon proteins in neurodegenerative disease$297,398
R01 · FY2007 · AG · contact PI
Roles of Reticulon proteins in neurodegenerative disease$306,280
R01 · FY2006 · AG · contact PI
Roles of Reticulon proteins in neurodegenerative disease$313,650
R01 · FY2005 · AG